Discovery of Seven ROS-Sensitive Immune Checkpoints and 46 Ligands Mediating Immune Suppression Through T cell-APC...

Area of Science:

• Immunology
• Molecular Biology

Background:

• The precise immune checkpoints (ICs) regulating CD4+FoxP3+ regulatory T cells (Tregs) are not fully understood.
• Existing knowledge of ICs primarily focuses on canonical pathways, leaving a gap in understanding Treg-mediated immune regulation.

Purpose of the Study:

• To comprehensively identify novel immune checkpoints and their ligands involved in Treg function.
• To elucidate the regulatory networks governing T cell-mediated immunity.

Main Methods:

• Transcriptomic screening of Treg membrane proteins to identify candidate ICs.
• Cross-referencing candidates with IC-deficient models and applying stringent criteria for validation.
• Ligand-receptor interaction mapping to identify associated ligands and their expression patterns.

Main Results:

• Seven novel immune checkpoints (CEP55, CD38, EHD4, CD200R1, PRC1, RAPH1, CD86) were identified on Tregs and other T cell subsets.
• 46 corresponding IC ligands were mapped, primarily expressed on antigen-presenting cells and tumor cells.
• Extensive regulatory networks involving these IC-ligand interactions were characterized.

Conclusions:

• A comprehensive immune checkpoint-ligand network, including seven novel ICs, has been delineated.
• This expanded landscape provides mechanistic insights into Treg and T cell regulation.
• New therapeutic avenues for cancer, autoimmune diseases, and other conditions are highlighted.